Marshall T Wise, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1606 Us Highway 27 N, Cynthiana, KY 41031 Phone: 859-234-8852 Fax: 859-234-8859 |
News Archive
The U.S. Food and Drug Administration today cleared a test called the Cepheid Xpert C. difficile/Epi assay that is designed to rapidly detect the toxin B gene associated with Clostridium difficile infection, a cause of diarrhea that can lead to colitis, other serious intestinal conditions and death in severe cases.
Burdens related to poor sleep may put men with sleep apnea at increased risk of erectile dysfunction. In a study of 713 male patients who visited Seoul National University Hospital for snoring and/or daytime sleepiness from 2006 to 2014, depressive symptoms and a low quality of life due to sleep problems were clearly linked to erectile dysfunction.
Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.
Childhood physical activity is related to long-term educational and labor market outcomes. According to Jaana Kari's dissertation, physically active children have better academic achievement at the end of compulsory basic education, and higher educational attainment and earnings as adult.
Progenics Pharmaceuticals, Inc. today announced the award of a grant totaling $4,143,652 from the National Institutes of Health (NIH) for Progenics' program to develop novel monoclonal antibodies to treat Clostridium difficile (C. difficile) infection.
› Verified 1 days ago